Archive for the ‘MRSA / Drug Resistance’ Category
Friday, April 11th, 2008
National multiple sclerosis charity the MS Trust has announced MS Awareness 2008 from 14th to 27th April. During MS Awareness, the Trust will be embarking on a number of high profile activities to demonstrate that you can embrace life with MS - with access to the right support and information, ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, April 11th, 2008
A nationally recognized faculty will present their latest multiple sclerosis related research findings and treatment protocols to medical professionals at the first annual MS 2008: Maximizing Care Strategies. Scheduled for May 3 at the Hyatt Regency Phoenix, the objectives of this multi-disciplinary conference are to expand the professionals' knowledge of ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, April 9th, 2008
A new research study being conducted at The Wesley Research Institute (WRI) aims to stop the progression of early active stage Multiple Sclerosis (MS) in its tracks.There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.They suffer from a ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, April 8th, 2008
Leaky blood vessels that lose their ability to protect the spinal cord from toxins may play a role in the development of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, according to research published in the April issue of Nature Neuroscience.The results mark the first time that ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, April 2nd, 2008
Unraveling how a drug helps patients with multiple sclerosisAlthough the drug IFN-beta is commonly used to treat individuals with the relapsing-remitting form of multiple sclerosis (MS), little is known about the mechanism(s) by which it acts. However, Genhong Cheng and colleagues, at the University of California at Los Angeles, have ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, March 28th, 2008
Sustaining hope in the face of a chronic, debilitating illness such as amyotrophic lateral sclerosis (ALS) should be a goal of palliative care and can take many forms, representing a continuum from focusing on the self to concern for others, as described in a paper published in the April issue ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, March 28th, 2008
The symptoms of multiple sclerosis (MS) that affect mobility have a significant impact on quality of life, safety, and financial and emotional health among many people living with MS, according to the results of two 2008 surveys conducted by Harris Interactive on behalf of Acorda Therapeutics, Inc. and the National ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, March 26th, 2008
Following news reports over the Easter weekend concerning the Embryology Bill currently making its way through Parliament, the MS Society has reinforced its position on this avenue of research.Simon Gillespie, chief executive of the MS Society, said: "The use of hybrid embryos is an important part of stem cell research."At ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, March 25th, 2008
The European Medicines Agency (EMEA) has concluded that warnings aboutliver injury should be added to the product information for Tysabri(natalizumab). Tysabri is used to treat relapsing-remitting multiple sclerosis (MS) inpatients with high disease activity despite treatment with abeta-interferon or whose disease is severe and evolving rapidly. Following a review of ...
Posted in MRSA / Drug Resistance | No Comments »
Saturday, March 22nd, 2008
Multiple Sclerosis is a debilitating autoimmune disease that affects the central nervous system. As nerve fiber is destroyed and damaged from the disease, even the most common every day tasks can be a chore. But with regular aquatic therapy, MS sufferers can strengthen weakened muscles and improve stamina ...
Posted in MRSA / Drug Resistance | No Comments »